These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31297350)

  • 1. Urinary transglutaminase 2 as a potent biomarker to predict interstitial fibrosis and tubular atrophy of kidney allograft during early posttransplant period in deceased donor kidney transplantation.
    Kim JY; Wee YM; Choi MY; Jung HR; Choi JY; Kwon HW; Jung JH; Cho YM; Go H; Han M; Kim YH; Han DJ; Shin S
    Ann Surg Treat Res; 2019 Jul; 97(1):27-35. PubMed ID: 31297350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A composite of urinary biomarkers for differentiating between tubulointerstitial inflammation and interstitial fibrosis/tubular atrophy in kidney allografts.
    Wee YM; Lee HW; Choi MY; Jung HR; Choi JY; Kwon HW; Jung JH; Kim YH; Han DJ; Shin S
    Ann Hepatobiliary Pancreat Surg; 2018 Nov; 22(4):310-320. PubMed ID: 30588521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter, prospective, observational study for urinary exosomal biomarkers of kidney allograft fibrosis.
    Kim MJ; Kwon HE; Jang HW; Kim JM; Lee JJ; Jung JH; Ko Y; Kwon H; Kim YH; Jun H; Park SJ; Gwon JG; Shin S
    Sci Rep; 2024 Sep; 14(1):20319. PubMed ID: 39223169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling of mRNA of interstitial fibrosis and tubular atrophy with subclinical inflammation in recipients after kidney transplantation.
    Fu Q; Liao M; Feng C; Tang J; Liao R; Wei L; Yang H; Markmann JF; Chen K; Deng S
    Aging (Albany NY); 2019 Jul; 11(14):5215-5231. PubMed ID: 31343413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies.
    Modena BD; Milam R; Harrison F; Cheeseman JA; Abecassis MM; Friedewald JJ; Kirk AD; Salomon DR
    Am J Transplant; 2017 Mar; 17(3):712-723. PubMed ID: 27597148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Expression of MicroRNAs Following Chronic Allograft Dysfunction with Interstitial Fibrosis and Tubular Atrophy.
    Soltaninejad E; Nicknam MH; Nafar M; Sharbafi MH; Keshavarz Shahbaz S; Barabadi M; Yekaninejad MS; Bahrami T; Ahmadpoor P; Amirzargar A
    Iran J Allergy Asthma Immunol; 2015 Dec; 14(6):615-23. PubMed ID: 26725559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary MicroRNA-21-5p as Potential Biomarker of Interstitial Fibrosis and Tubular Atrophy (IFTA) in Kidney Transplant Recipients.
    Gniewkiewicz MS; Paszkowska I; Gozdowska J; Czerwinska K; Sadowska-Jakubowicz A; Deborska-Materkowska D; Perkowska-Ptasinska A; Kosieradzki M; Durlik M
    Diagnostics (Basel); 2020 Feb; 10(2):. PubMed ID: 32092939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of urinary miR-21 and miR-200b associated with interstitial fibrosis and tubular atrophy (IFTA) in renal transplant recipients.
    Zununi Vahed S; Omidi Y; Ardalan M; Samadi N
    Clin Biochem; 2017 Jan; 50(1-2):32-39. PubMed ID: 27521993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower Circulating Cytotoxic T-Cell Frequency and Higher Intragraft Granzyme-B Expression Are Associated with Inflammatory Interstitial Fibrosis and Tubular Atrophy in Renal Allograft Recipients.
    Yadav B; Prasad N; Agrawal V; Agarwal V; Jain M
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374379
    [No Abstract]   [Full Text] [Related]  

  • 10. Urine Angiotensin II Signature Proteins as Markers of Fibrosis in Kidney Transplant Recipients.
    Mohammed-Ali Z; Tokar T; Batruch I; Reid S; Tavares-Brum A; Yip P; Cardinal H; Hébert MJ; Li Y; Kim SJ; Jurisica I; John R; Konvalinka A
    Transplantation; 2019 Jun; 103(6):e146-e158. PubMed ID: 30801542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies.
    García-Carro C; Dörje C; Åsberg A; Midtvedt K; Scott H; Reinholt FP; Holdaas H; Seron D; Reisæter AV
    Transplantation; 2017 Jun; 101(6):1410-1415. PubMed ID: 27163535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long-Term Outcomes.
    Modena BD; Kurian SM; Gaber LW; Waalen J; Su AI; Gelbart T; Mondala TS; Head SR; Papp S; Heilman R; Friedewald JJ; Flechner SM; Marsh CL; Sung RS; Shidban H; Chan L; Abecassis MM; Salomon DR
    Am J Transplant; 2016 Jul; 16(7):1982-98. PubMed ID: 26990570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allografts.
    Ho J; Rush DN; Gibson IW; Karpinski M; Storsley L; Bestland J; Stefura W; HayGlass KT; Nickerson PW
    Transplantation; 2010 Aug; 90(4):394-400. PubMed ID: 20625355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of urinary volatile organic compounds as a novel metabolomic biomarker to assess chronic kidney disease progression.
    Wu HHL; Possell M; Nguyen LT; Peng W; Pollock CA; Saad S
    BMC Nephrol; 2024 Oct; 25(1):352. PubMed ID: 39407183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of early conversion from tacrolimus to sirolimus on chronic allograft changes in kidney recipients on rapid steroid withdrawal.
    Heilman RL; Cortese C; Geiger XJ; Younan K; Wadei HM; Mai ML; Reddy KS; Gonwa TA
    Transplantation; 2012 Jan; 93(1):47-53. PubMed ID: 22067270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney Tubulointerstitial Fibrosis and Tubular Secretion.
    Garimella PS; Katz R; Waikar SS; Srivastava A; Schmidt I; Hoofnagle A; Palsson R; Rennke HG; Stillman IE; Wang K; Kestenbaum BR; Ix JH
    Am J Kidney Dis; 2022 May; 79(5):709-716. PubMed ID: 34571064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-vimentin Antibodies Present at the Time of Transplantation May Predict Early Development of Interstitial Fibrosis/Tubular Atrophy.
    Lopez-Soler RI; Borgia JA; Kanangat S; Fhied CL; Conti DJ; Constantino D; Ata A; Chan R; Wang Z
    Transplant Proc; 2016; 48(6):2023-33. PubMed ID: 27569939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of anti-vimentin antibodies in renal transplantation.
    Besarani D; Cerundolo L; Smith JD; Procter J; Barnardo MC; Roberts IS; Friend PJ; Rose ML; Fuggle SV
    Transplantation; 2014 Jul; 98(1):72-8. PubMed ID: 24978037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary chemokine C-X-C motif ligand 16 and endostatin as predictors of tubulointerstitial fibrosis in patients with advanced diabetic kidney disease.
    Lee YH; Kim KP; Park SH; Kim DJ; Kim YG; Moon JY; Jung SW; Kim JS; Jeong KH; Lee SY; Yang DH; Lim SJ; Woo JT; Rhee SY; Chon S; Choi HY; Park HC; Jo YI; Yi JH; Han SW; Lee SH
    Nephrol Dial Transplant; 2021 Jan; 36(2):295-305. PubMed ID: 31598726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the heparan sulphate-dependent externalisation of transglutaminase-2 (TG2) in glucose-stimulated proximal-like tubular epithelial cells.
    Furini G; Burhan I; Huang L; Savoca MP; Atobatele A; Johnson T; Verderio EAM
    Anal Biochem; 2020 Aug; 603():113628. PubMed ID: 32074489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.